Ventracor's "artificial heart" shows early promise:
This article was originally published in Clinica
Ventracor has reported promising early results from a pilot trial of its "artificial heart", VentrAssist, which is designed for use in patients who are not eligible for heart transplantation and are no longer responding to optimal medical therapy. The first patient to be implanted with the device - a left ventricular assist system - has made an excellent early recovery and was discharged to his home on August 19, said the Sydney, Australia firm. The patient, who received the device in June this year, is the first of 10 patients who are taking part in the trial. The trial is being conducted at The Alfred hospital in Melbourne.